HER2 Mutations in Non-Small-Cell Lung Cancer Can Be Continually Targeted

被引：20
|
作者：
Kelly, Ronan J. [1 ]
Carter, Corey A. [2 ]
Giaccone, Giuseppe [3 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Natl Naval Med Ctr, Bethesda, MD USA
[3] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 26期
关键词：
PHASE-II; TRASTUZUMAB;
D O I：
10.1200/JCO.2012.43.4902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3318 / 3319
页数：4
相关论文
共 50 条
  • [1] HER2 AND BRAF MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Estival, Anna
    Carcereny, Enric
    Indacochea, Alberto
    Luis Ramirez, Jose
    Moran, Teresa
    Luis Cuadra, Jose
    Vila, Laia
    Gil, Maria
    Botia, Monica
    Perez, M.
    Tierno, M.
    Capdevila, Laia
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S957 - S957
  • [2] Mutational Subtypes and Prognosis of Non-Small-Cell Lung Cancer Harboring HER2 Mutations
    Xu, C.
    Wang, W.
    Zhuang, W.
    Huang, Z.
    Song, Z.
    Chen, Y.
    Liu, W.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1940 - S1940
  • [3] Consensus for HER2 alterations testing in non-small-cell lung cancer
    Ren, S.
    Wang, J.
    Ying, J.
    Mitsudomi, T.
    Lee, D. H.
    Wang, Z.
    Chu, Q.
    Mack, P. C.
    Cheng, Y.
    Duan, J.
    Fan, Y.
    Han, B.
    Hui, Z.
    Liu, A.
    Liu, J.
    Lu, Y.
    Ma, Z.
    Shi, M.
    Shu, Y.
    Song, Q.
    Song, X.
    Song, Y.
    Wang, C.
    Wang, X.
    Wang, Z.
    Xu, Y.
    Yao, Y.
    Zhang, L.
    Zhao, M.
    Zhu, B.
    Zhang, J.
    Zhou, C.
    Hirsch, F. R.
    [J]. ESMO OPEN, 2022, 7 (01)
  • [4] Pilot evaluation of a HER2 testing in non-small-cell lung cancer
    Hotta, Katsuyuki
    Yanai, Hiroyuki
    Ohashi, Kadoaki
    Ninomiya, Kiichiro
    Nakashima, Hiromi
    Kayatani, Hiroe
    Takata, Minoru
    Kiura, Katsuyuki
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (06) : 353 - 357
  • [5] HER2: defining a Neu target in non-small-cell lung cancer
    Ekman, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (03) : 353 - 355
  • [6] HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer
    Cappuzzo, F
    Bemis, L
    Varella-Garcia, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24): : 2619 - 2621
  • [7] "New Targets in Non-Small-Cell Lung Cancer"-RET, HER2, and KRAS
    Halani, Varun
    Sharayah, Ahmad
    Beck, Bryan
    Patolia, Setu
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (06) : 748 - 749
  • [8] Targeting HER2 Alterations in Non-Small-Cell Lung Cancer: A Comprehensive Review
    Zhao, Jing
    Xia, Yang
    [J]. JCO PRECISION ONCOLOGY, 2020, 4 : 411 - 425
  • [9] EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer
    Toshihiko, Yokoyama
    Kondo, Masashi
    Goto, Yasuhiro
    Fukui, Takayuki
    Yoshioka, Hiromu
    Yokoi, Kohei
    Kondo, Yutaka
    Osada, Hirotaka
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Sekido, Yoshitaka
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    [J]. ONCOTARGET, 2016, 7 (47) : 78152 - 78158
12345